387 related articles for article (PubMed ID: 19029933)
21. AMPK links energy status to cell structure and mitosis.
Koh H; Chung J
Biochem Biophys Res Commun; 2007 Nov; 362(4):789-92. PubMed ID: 17709095
[TBL] [Abstract][Full Text] [Related]
22. A new role of NUAK1: directly phosphorylating p53 and regulating cell proliferation.
Hou X; Liu JE; Liu W; Liu CY; Liu ZY; Sun ZY
Oncogene; 2011 Jun; 30(26):2933-42. PubMed ID: 21317932
[TBL] [Abstract][Full Text] [Related]
23. Cancer risks in LKB1 germline mutation carriers.
Mehenni H; Resta N; Park JG; Miyaki M; Guanti G; Costanza MC
Gut; 2006 Jul; 55(7):984-90. PubMed ID: 16407375
[TBL] [Abstract][Full Text] [Related]
24. Targeting LKB1 signaling in cancer.
Korsse SE; Peppelenbosch MP; van Veelen W
Biochim Biophys Acta; 2013 Apr; 1835(2):194-210. PubMed ID: 23287572
[TBL] [Abstract][Full Text] [Related]
25. Mutation of Lkb1 and p53 genes exert a cooperative effect on tumorigenesis.
Wei C; Amos CI; Stephens LC; Campos I; Deng JM; Behringer RR; Rashid A; Frazier ML
Cancer Res; 2005 Dec; 65(24):11297-303. PubMed ID: 16357136
[TBL] [Abstract][Full Text] [Related]
26. LKB1 catalytically deficient mutants enhance cyclin D1 expression.
Scott KD; Nath-Sain S; Agnew MD; Marignani PA
Cancer Res; 2007 Jun; 67(12):5622-7. PubMed ID: 17575127
[TBL] [Abstract][Full Text] [Related]
27. Frequency and spectrum of cancers in the Peutz-Jeghers syndrome.
Hearle N; Schumacher V; Menko FH; Olschwang S; Boardman LA; Gille JJ; Keller JJ; Westerman AM; Scott RJ; Lim W; Trimbath JD; Giardiello FM; Gruber SB; Offerhaus GJ; de Rooij FW; Wilson JH; Hansmann A; Möslein G; Royer-Pokora B; Vogel T; Phillips RK; Spigelman AD; Houlston RS
Clin Cancer Res; 2006 May; 12(10):3209-15. PubMed ID: 16707622
[TBL] [Abstract][Full Text] [Related]
28. The LKB1/AMPK polarity pathway.
Mirouse V; Billaud M
FEBS Lett; 2011 Apr; 585(7):981-5. PubMed ID: 21185289
[TBL] [Abstract][Full Text] [Related]
29. Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation.
Bardeesy N; Sinha M; Hezel AF; Signoretti S; Hathaway NA; Sharpless NE; Loda M; Carrasco DR; DePinho RA
Nature; 2002 Sep; 419(6903):162-7. PubMed ID: 12226664
[TBL] [Abstract][Full Text] [Related]
30. The molecular mechanisms that underlie the tumor suppressor function of LKB1.
Fan D; Ma C; Zhang H
Acta Biochim Biophys Sin (Shanghai); 2009 Feb; 41(2):97-107. PubMed ID: 19204826
[TBL] [Abstract][Full Text] [Related]
31. The LKB1 tumor suppressor kinase in human disease.
Katajisto P; Vallenius T; Vaahtomeri K; Ekman N; Udd L; Tiainen M; Mäkelä TP
Biochim Biophys Acta; 2007 Jan; 1775(1):63-75. PubMed ID: 17010524
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.
Sanchez-Cespedes M; Parrella P; Esteller M; Nomoto S; Trink B; Engles JM; Westra WH; Herman JG; Sidransky D
Cancer Res; 2002 Jul; 62(13):3659-62. PubMed ID: 12097271
[TBL] [Abstract][Full Text] [Related]
33. Lkb1 is required for TGFbeta-mediated myofibroblast differentiation.
Vaahtomeri K; Ventelä E; Laajanen K; Katajisto P; Wipff PJ; Hinz B; Vallenius T; Tiainen M; Mäkelä TP
J Cell Sci; 2008 Nov; 121(Pt 21):3531-40. PubMed ID: 18840652
[TBL] [Abstract][Full Text] [Related]
34. A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity.
Martin SG; St Johnston D
Nature; 2003 Jan; 421(6921):379-84. PubMed ID: 12540903
[TBL] [Abstract][Full Text] [Related]
35. Accelerated onsets of gastric hamartomas and hepatic adenomas/carcinomas in Lkb1+/-p53-/- compound mutant mice.
Takeda H; Miyoshi H; Kojima Y; Oshima M; Taketo MM
Oncogene; 2006 Mar; 25(12):1816-20. PubMed ID: 16278673
[TBL] [Abstract][Full Text] [Related]
36. At the crossroads: AMP-activated kinase and the LKB1 tumor suppressor link cell proliferation to metabolic regulation.
Kyriakis JM
J Biol; 2003; 2(4):26. PubMed ID: 14575531
[TBL] [Abstract][Full Text] [Related]
37. The tumor suppressor LKB1 induces p21 expression in collaboration with LMO4, GATA-6, and Ldb1.
Setogawa T; Shinozaki-Yabana S; Masuda T; Matsuura K; Akiyama T
Biochem Biophys Res Commun; 2006 May; 343(4):1186-90. PubMed ID: 16580634
[TBL] [Abstract][Full Text] [Related]
38. The LKB1 tumor suppressor negatively regulates mTOR signaling.
Shaw RJ; Bardeesy N; Manning BD; Lopez L; Kosmatka M; DePinho RA; Cantley LC
Cancer Cell; 2004 Jul; 6(1):91-9. PubMed ID: 15261145
[TBL] [Abstract][Full Text] [Related]
39. Utilization of liquid chromatography mass spectrometry analyses to identify LKB1-APC interaction in modulating Wnt/β-catenin pathway of lung cancer cells.
Jian SF; Hsiao CC; Chen SY; Weng CC; Kuo TL; Wu DC; Hung WC; Cheng KH
Mol Cancer Res; 2014 Apr; 12(4):622-35. PubMed ID: 24448687
[TBL] [Abstract][Full Text] [Related]
40. Altered LKB1/CREB-regulated transcription co-activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion.
Gu Y; Lin S; Li JL; Nakagawa H; Chen Z; Jin B; Tian L; Ucar DA; Shen H; Lu J; Hochwald SN; Kaye FJ; Wu L
Oncogene; 2012 Jan; 31(4):469-79. PubMed ID: 21706049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
